PANK4 and glioblastoma: Our aforementioned cell‐based assays demonstrated that while silencing of PANK4 displays modest phenotypic effects, PANK4 knockdown in combination with TMZ treatment significantly potentiates TMZ cytotoxicity, sensitizing TMZ‐resistant GBM cells to the drug.